See All Slides - tctmd.com

Slides

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

Presenter: Mark C. Bates, Mark H. Wholey, Konstantinos Marmagkiolis

October 13, 2015

Presentation TCT 2015

TCT 36: Quantification of the Effect of Measurement Drift on the Diagnostic Performance of FFR, iFR, and Whole Cycle Pd/Pa

Presenter: Javier Escaned, Johan HC Reiber, Christopher Cook

October 13, 2015

Presentation TCT 2015

TCT 2: Early or Late Intervention in Patients With Transient ST-Segment Elevation Acute Coronary Syndrome Subgroup Analysis of the ELISA-3 Trial

Presenter: Eric Boersma, Richard Smalling, Erik Badings

October 13, 2015

Presentation TCT 2015

TCT 44: The Impact of Plaque Morphology and Malapposition Area on Late-Phase Stent Malapposition Insight From the Optimal Coherence Tomography Substudy in PRASFIT Elective

Presenter: Stephan Achenbach, Marc D. Feldman, Kenzo Uzu

October 13, 2015

Advertisement

Slides

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

TCT 36: Quantification of the Effect of Measurement Drift on the Diagnostic Performance of FFR, iFR, and Whole Cycle Pd/Pa

TCT 2: Early or Late Intervention in Patients With Transient ST-Segment Elevation Acute Coronary Syndrome Subgroup Analysis of the ELISA-3 Trial

TCT 44: The Impact of Plaque Morphology and Malapposition Area on Late-Phase Stent Malapposition Insight From the Optimal Coherence Tomography Substudy in PRASFIT Elective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content